
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
This award is given to a pharmacist dedicated to improving his or her community, particularly when the vision is related to pharmacy care.
This video features the winner and honorees for the 2013 Next-Generation PharmacistTM Civic Leader of the Year award, presented by Pharmacy Times and Parata Systems:






